Unfortunately in this study, HERC5 DNA loss was only evaluated in the 4 HCC patients with matched primary and recurrent tumor specimens, since DNA sequencing was not conducted on the remaining 17 HCC patients. The gene discussed is HERC5; the disease is neoplasm.